stockrowXeris Biopharma Holdings, Inc.
XERS Healthcare Drug Manufacturers Specialty & Generic
Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024.
- Revenue
- +44.2%
- EPS
- +1,479.0%
- Free cash flow
- +93.2%
- Total debt
- −13.6%
Quarter to September 2026, against a year earlier
Follow XERS
Alert me
Xeris Biopharma Holdings, Inc. (XERS) Gross margin
Xeris Biopharma Holdings, Inc.'s gross margin over the twelve months to 30 September 2026 was 87.4%, up 2.0 percentage points from fiscal 2025 (85.4%). Over the past ten years it has ranged from 41.1% (fiscal 2019) to 100.0% (fiscal 2018); the current reading is higher than 70% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 54.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 85.4% | 3.55 |
| FY2024 | 81.9% | (0.66) |
| FY2023 | 82.5% | 3.05 |
| FY2022 | 79.5% | 6.33 |
| FY2021 | 73.1% | 18.79 |
| FY2020 | 54.4% | 13.24 |
| FY2019 | 41.1% | (58.89) |
| FY2018 | 100.0% | 0.26 |
| FY2017 | 99.7% | 0.48 |
| FY2016 | 99.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 88.4% | 2.00 |
| Jun 2026 | 86.4% | (0.87) |
| Mar 2026 | 87.3% | 0.04 |
| Dec 2025 | 87.2% | 2.02 |
| 33 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | 97.9% |
| XERS Xeris Biopharma Holdings, Inc. | 87.4% |
| TRLV Trulieve Cannabis Corp. compare | 60.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| ALVO Alvotech compare | 42.7% |
| PRGO Perrigo Company plc compare | 32.3% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −42.7% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 54.5% |
| Market median | 46.0% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on XERS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement